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Allelic Skewing of DNA Methylation
Is Widespread across the Genome
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Aaron R. Jeffries,2 Matthew N. Davies,1 Robert Plomin,1 and Jonathan Mill1,*
DNAmethylation is assumed to be complementary on both alleles across the genome, although there are exceptions, notably in regions
subject to genomic imprinting. We present a genome-wide survey of the degree of allelic skewing of DNA methylation with the aim of
identifying previously unreported differentially methylated regions (DMRs) associated primarily with genomic imprinting or DNA
sequence variation acting in cis. We used SNP microarrays to quantitatively assess allele-speciﬁc DNA methylation (ASM) in amplicons
covering 7.6% of the human genome following cleavage with a cocktail of methylation-sensitive restriction enzymes (MSREs). Selected
ﬁndings were veriﬁed using bisulﬁte-mapping and gene-expression analyses, subsequently tested in a second tissue from the same indi-
viduals, and replicated in DNA obtained from 30 parent-child trios. Our approach detected clear examples of ASM in the vicinity of
known imprinted loci, highlighting the validity of themethod. In total, 2,704 (1.5%) of our 183,605 informative and stringently ﬁltered
SNPs demonstrate an average relative allele score (RAS) changeR0.10 followingMSRE digestion. In agreement with previous reports, the
majority of ASM (~90%) appears to be cis in nature, and several examples of tissue-speciﬁc ASMwere identiﬁed. Our data show that ASM
is a widespread phenomenon, with >35,000 such sites potentially occurring across the genome, and that a spectrum of ASM is likely,
with heterogeneity between individuals and across tissues. These ﬁndings impact our understanding about the origin of individual
phenotypic differences and have implications for genetic studies of complex disease.Introduction
DNA methylation is a key epigenetic mechanism involved
in the developmental regulation of gene expression.1 Alter-
ations in DNA methylation are known to contribute to
interindividual phenotypic variation and have been linked
to the onset of cancer2 and complex disease phenotypes
such as major psychosis.3 Across the majority of the
genome, DNA methylation is assumed to be complemen-
tary on both alleles, although there are several instances
where it can be allele-speciﬁc.
First, DNA methylation plays an integral role in regu-
lating the parental-origin-dependent allele-speciﬁc expres-
sion (ASE) of imprinted loci. Only ~40–50 genes have been
shown to be classically imprinted in humans, but more
subtle parental-origin effects on gene expression are specu-
lated to be much more widespread.4 Identifying the
speciﬁc location of functional elements regulating
imprinting is difﬁcult; monoallelic expression is typically
regulated by allele-speciﬁc DNA methylation (ASM) at
discrete imprinting control elements (ICEs), which encom-
pass differentially methylated regions (DMRs) often only
a few kb in length. Imprinted genes normally occur in clus-
ters, and monoallelic expression across numerous loci can
be controlled by ASM at a single DMR. Traditional
approaches to identifying DMRs have focused on known
imprinted regions and looked for patterns of completely
biphasic DNA methylation. It is likely, however, that
many allele-speciﬁc effects are relatively subtle, character-
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of the genome, believed to exhibit monoallelic expression,
can show considerable epigenetic heterogeneity in their
expression.5 A second, related type of ASM occurs in
females, where DNA methylation coordinates the random
silencing of either X chromosome to ensure dosage
compensation with males in a process called X chromo-
some inactivation.6 X inactivation in any given cell is typi-
cally random and is maintained once established so that
the inactivated allele is transcriptionally silenced.
Examples of a third type of ASM have recently been re-
ported, whereby genotype exerts an inﬂuence upon DNA
methylation in cis.7–9 Such patterns have been postulated
to provide a mechanism behind the common ASE differ-
ences observed throughout the genome10–15 and provide
a functional role for seemingly synonymous DNA se-
quence changes. Several examples of ASM occurring in
cis with genotype have been uncovered on chromosome
21,9,16,17 and recent evidence suggests that genotype-asso-
ciated ASM is common in both human and mice.7,8 cis
effects on gene expression, mediated by ASM, have been
widely identiﬁed in malignant cells,18 but the degree to
which they operate in normal cellular systems has yet to
be systematically ascertained.
In this study, we applied an informative enrichment
strategy and high-resolution microarrays to assess the full
extent of human genomic ASM. We report numerous
examples of allelically skewed DNA methylation across
the genome. The majority appear to be cis in nature, and
we also uncover previously unreported DMRs where ASMchiatry, King’s College London, London SE5 8AF, UK; 3Birkbeck College,
Genetics. All rights reserved.
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is mediated by parental origin. We report several examples
of tissue-speciﬁc ASM and show that many ASM-associated
SNPs are linearly associated with gene expression.
Material and Methods
Samples
The initial sampling frame for our genome-wide ASM screen was
the Twins Early Development Study (TEDS), a longitudinal study
of behavioral development in a representative sample of twins
born in 1994, 1995, and 1996 who have been followed from
infancy through adolescence.19 All twins and parents involved
in TEDS provide informed consent for each stage of the study.
Ethical approval for the TEDS has been provided by the King’s
College London (UK) ethics committee. From a sample of healthy
pairs of 12-year-old monozygotic (MZ) twins, ﬁve pairs were
selected: four female pairs and one male pair (n ¼ 10). Venous
blood samples were obtained from each individual and used to
prepare both DNA and RNA using standard protocols. In addition,
3 ml blood was collected from each subject to assess differences in
cell subtype compositions that could inﬂuence interindividual
expression proﬁles. All cell subtype counts were in the normal
range and comparable across subjects. Finally, buccal swabs were
obtained from each individual and used to prepare DNA from
a second tissue.20
Genome-wide Analysis of ASM
For each individual, Affymetrix SNP 6.0 arrays (Affymetrix; High
Wycombe, UK) were used to genotype (1) standard genomic
DNA (denoted as G), (2) DNA digested with a cocktail of methyla-
tion-sensitive restriction enzymes (MSREs) (denoted as D), and (3)
whole-genome-ampliﬁed fully unmethylated DNA digested with
a cocktail of MSREs (denoted as U) (to control for the effect of
SNPs at enzyme cleavage sites). DNA from each individual (1 mg)
was digested using a cocktail of three MSREs: HpaII (50-CˆC G
G-30), HhaI (50-G C GˆC-30), and AciI (50-CˆC G C-30), which in
combination interrogate the methylation status of ~32.4% of
CpG sites in the human genome.21 Unmethylated DNA from
each individual was produced by whole-genome-amplifying
100 ng DNA using the QIAGEN REPLI-g kit (QIAGEN; Crawley,
UK) following the manufacturer’s protocol.
Analysis of ASM Microarray Data
To enable us to quantitatively measure the degree of ASM, we
applied novel analytical techniques originally developed to assess
SNP allele frequencies in DNA pools,22,23 which allowed us to
accurately identify allelic skewing in addition to allelic switching
following MSRE digestion. In order to compare arrays hybridized
with uncut genomic DNA (G) to those hybridized with MSRE-di-
gested (D) or artiﬁcially demethylated and then MSRE-digested
(U) DNA, we scaled the raw intensities for each array by a constant
to bring the mean of the 0.90–0.95 quantiles to the same value as
the mean of these quantiles for the U arrays. The rationale here
was that the strongest signals on the U arrays would be from am-
plicon fragments without MSRE sites, and these should be equal
across all arrays. At the same time, the very highest few percentiles
could be enriched in artifacts and therefore more variable. Because
they are expected to have differing distributions, each of the G, D,
and U groups was subsequently individually quantile-normalized.
Relative allele score (RAS) values were generated using an updated
version of our SNPMaP package (v1.02) in R,22 developed speciﬁ-The Americacally for these analyses and available for download (see Web
Resources). RAS is deﬁned as A/(A þ B), where A and B are the
intensities of the probes for the two alleles for a given SNP, and
has been validated as an accurate estimator of allele frequency in
pools of DNA.23 For a given SNP in a heterozygous individual,
a difference in RAS score between G and D arrays is indicative
of ASM.
We applied a highly stringent ﬁltering process to remove SNPs
located in noninformative amplicons (Table S1 and Figure S1)
and processed artiﬁcially unmethylated DNA from each individual
in parallel to control for polymorphic MSRE sites. Amplicon frag-
ment coordinates were obtained from the Affymetrix annotation
ﬁle GenomeWideSNP_6.na27.annot.csv (corresponding to UCSC
hg18) downloaded from the Affymetrix website. Fragment
sequences were downloaded usingGalaxy and searched to identify
those with one or more MSRE cut-sites. Because the Affymetrix 6.0
assay involves preparing both NspI and StyI amplicons, SNPs can
be on one or two fragments, each of which can have anMSRE site.
There are thus ﬁve classes of SNPs potentially generated by our
approach: a (one amplicon generated [StyI or NspI] with a MSRE
cut-site), b (two amplicons generated [StyI and NspI], both con-
taining a MSRE cut-site), c (one amplicon generated [StyI or
NspI] with no MSRE cut-site), d (two amplicons generated [StyI
and NspI] with neither containing a MSRE cut-site), and e (two
amplicons generated [StyI and NspI] with only one containing a
MSRE cut-site) (Table S1). As expected, plotting intensity ratios
for the ﬁve classes of SNP from our normalized microarray data
demonstrates that informative SNPs (class a and class b) have
different U/G signal ratios compared to noninformative SNPs
(class c, class d, and class e) (Figure S1). In addition to selecting
only informative SNPs, we also required that SNPs were heterozy-
gous in at least one MZ twin pair, did not show genotype discor-
dance within MZ twin pairs, and passed a standard quality
threshold across all arrays. Finally, SNPs yielding a variable U/G
ratio (SD > 0.07) across all samples were removed to further
control against inaccurate measures of ASM due to possible DNA
sequence/copy-number variation polymorphisms. Raw data and
a UCSC browser track showing the amplicon fragments and their
informativeness in this assay is available for viewing and down-
load from our group website.Veriﬁcation of Microarray Data
In order to verify data from the microarray analyses, ten SNPs
showing high RAS changes indicative of ASM were subsequently
tested using independent SNP-speciﬁc genotyping methods.
Genomic DNA and unmethylated (whole-genome-ampliﬁed)
DNA from the same ten individuals was independently digested
with MSREs as described above. In addition to whole-blood
DNA, we also processed buccal cell DNA from each individual to
assess the tissue speciﬁcity of any allelically skewed DNA methyl-
ation. PCRs were designed to span the SNP and any potentially
informative MSRE cut-sites within the NspI and/or StyI amplicons
used in the Affymetrix protocol (Table S2). SNP genotype was
quantitatively assessed using the ABI SNaPshot Single Nucleotide
Primer Extension assay followed by shrimp alkaline phosphatase
(SAP) treatment and electrophoresis on an ABI 3300 (Applied Bio-
systems) using the manufacturer’s protocol.DNA Methylation Analysis across Veriﬁed Regions
DNAmethylation at MSRE cut-sites located in the Affymetrix PCR
amplicons containing the SNPs selected for veriﬁcation wasn Journal of Human Genetics 86, 196–212, February 12, 2010 197
initially assessed using Methylation-Sensitive Single Nucleotide
Primer Extension (MS-SNuPE) as described by Kaminsky et al.24
In brief, 500 ng of genomic DNAwas treated with sodium bisulﬁte
as previously described3 and ampliﬁed using bisulﬁte-PCR. The
ABI SNaPshot assay was used to quantify the relative proportion
of DNA molecules methylated at each potential cut-site using
the ABI SNaPshot Single Nucleotide Primer Extension assay
followed by SAP treatment and electrophoresis on an ABI 3300
(Applied Biosystems) as described above. All bisulﬁte-based anal-
yses included fully methylated and fully unmethylated control
samples to ensure the validity of our data. Bisulﬁte primer
sequences are presented in Table S2. A number of regions were
subsequently selected for in-depth clonal bisulﬁte sequencing
analysis to further verify our ﬁndings and determine the precise
allele-speciﬁc patterns of DNA methylation. Following sodium
bisulﬁte treatment and bisulﬁte-PCR ampliﬁcation, amplicons
were cloned using the TOPO TA cloning method (Invitrogen;
Paisley, UK) and sequenced with BigDye v1.1 sequencing chem-
istry (Applied Biosystems), with 24–32 clones sequenced per
amplicon. Sequencing traces were visualized, quality controlled,
and aligned using BiQ Analyzer.25 All data were tested for complete
sodium bisulﬁte conversion, with an overall conversion rate
>99.9% estimated by BiQ Analyzer.
Replication of Selected ASM Effects in Independent
Samples
We obtained 90 Centre d’Etude du Polymorphisme Humain
(CEPH) genomic DNA samples extracted from transformed
lymphoblastoid cell lines (Coriell Institute for Medical Research;
Camden, NJ). The samples originated from 30 families (n ¼ 30
mothers, n¼ 30 fathers, and n¼ 30 offspring), enabling us to infer
both parental-origin and cis ASM effects. An aliquot of each
sample was digested to completion with a cocktail of MSREs as
described above. SNP genotype was quantitatively assessed in
both undigested and digested samples using the ABI SNaPshot
Single Nucleotide Primer Extension assay followed by SAP treat-
ment and electrophoresis on an ABI 3300 (Applied Biosystems)
as described above.
Gene Expression Analysis
Given that DNA methylation is linked to the regulation of gene
expression,1 we postulated that ASM-associated SNPs might be
linearly associated with the expression of nearby genes. Reliable
estimates of gene expressionwere obtained from the same samples
by proﬁling whole-blood mRNA from each individual four times
over a 10 month period.26 Total RNA was obtained using the
PAXgene Blood RNA Kit protocol (PreAnalytiXGmbH; Hombrech-
tikon, Switzerland). Expression proﬁles were generated by hybrid-
izing cRNA derived from 5 mg total RNA to Affymetrix U133 Plus
2.0 Arrays (Affymetrix; Santa Clara, CA) in accordance with the
Affymetrix Eukaryotic One-Cycle protocol with integrated globin
reduction. Microarray data are MIAME compliant and available to
download at the Gene Expression Omnibus website under the
accession number GSE14844.Results
Methodological Overview
A graphical overview explaining our methodological
approach is given in Figure 1, and speciﬁc details are given
in the Material and Methods section (above). In brief,198 The American Journal of Human Genetics 86, 196–212, Februaryusing whole-blood DNA from ten individuals in ﬁve MZ
twin pairs, with twins serving as independent genetically
identical biological replicates, we employed high-resolu-
tion microarrays to quantitatively assess changes in RAS
at ~1 million SNPs following digestion with MSREs. We
applied a highly stringent ﬁltering process to remove
SNPs located in noninformative amplicons and processed
artiﬁcially unmethylated DNA from each individual in
parallel to control for polymorphic MSRE sites. To enable
us to quantitatively measure the degree of ASM, we applied
novel analytical techniques originally developed to assess
SNP allele frequencies in DNA pools,22,23 allowing us to
accurately identify allelic skewing in addition to complete
allelic switching across the population of DNA molecules
present in each sample following MSRE digestion. In order
to conﬁrm data from the microarray analyses, ten SNPs
showing high RAS changes indicative of ASM were subse-
quently tested using independent SNP-speciﬁc genotyping
methods. Selected ﬁndings were independently veriﬁed in
a second cell type (buccal) from the same individuals and
replicated in 90 familial DNA samples obtained from the
CEPH pedigrees. DNA methylation across multiple ASM-
associated regions was assessed using bisulﬁte mapping
to conﬁrm that our observations resulted from differential
methylation. Finally, using RNA samples from the same
initial set of subjects, we tested to see whether ASM-associ-
ated SNPs are also associated with gene expression
changes.
Genome-wide Patterns of ASM
In total, 183,605 informative SNPs, located in amplicons
covering 7.6% of the human genome, passed our strin-
gent ﬁltering criteria (see Material and Methods) and
gave heterozygous genotype calls in at least one twin
pair. A UCSC browser track showing the location of all
informative SNP-containing amplicons is available for
download from our group website. For each of these
SNPs, we calculated the average RAS difference in hetero-
zygous individuals following MSRE digestion and microar-
ray analysis (see Figure S2 for genome-wide distribution).
In total, we identiﬁed 2704 (1.5%) SNPs with an average
RAS change R0.10. Extrapolating these ﬁndings to the
remainder of the genome suggests that >35,000 such
ASM-associated sites probably exist. Table 1 lists those
SNPs showing the greatest degree of ASM with an average
RAS change >0.30. ASM data for each of the samples
proﬁled using this method are available to view as down-
loadable tracks in the UCSC Genome Browser from our
website. In order to estimate the proportion of ASM deter-
mined by (1) local genotype (i.e., cis effects) and (2) other
factors (i.e., trans effects, parental origin, or stochasticity),
we assessed the consistency in direction of RAS change
across heterozygous samples. Of the 2704 informative
SNPs with a RAS change R0.10 for which there are three
or more heterozygous genotypes, the majority (90.3%)
appear to be associated with cis-acting ASM. This is in
broad agreement with a recent study reporting that ASM12, 2010
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Figure 1. Outline of the Experimental Approach Used to Identify Allele-Specific DNA Methylation
Genomic DNA samples were digested with a cocktail of three methylation-sensitive restriction enzymes (MSREs). In parallel, artiﬁcially
unmethylated DNA from each individual was digested using the same cocktail of enzymes to act as a control for the effect of genetic
variation at MSRE cut-sites. Samples were subsequently genotyped on Affymetrix 6.0 genotyping microarrays with complete allele-
speciﬁc DNAmethylation (ASM), causing a switch from a heterozygous genotype call to a monoallelic genotype call in digested samples.
To assess more quantitatively skewed ASM, we assessed relative allele score (RAS) changes in digested samples. Black circles denote
methylated CpG dinucleotides. White circles denote unmethylated CpG dinucleotides.in mouse strains is primarily determined by cis-acting
factors,7 but it is noticeable that at least 9.7% of ASM-asso-
ciated SNPs in our study show some inconsistency in
skewing, indicating they are unlikely to be cis in nature.
In reality, this proportion is likely to be higher, given
that some non-cis ASM effects will go in the same direc-
tion across all heterozygous individuals by chance in the
samples we processed.
Veriﬁcation of Microarray Data and Replication
in Additional Samples
We selected ten ASM-associated SNPs from our microarray
screen for independent veriﬁcation and further investiga-The Americation. Individual examples are discussed in detail in the
sections below, but in all cases we were able to conﬁrm
the results of the microarray analysis, suggesting that our
approach and stringent ﬁltering techniques provide an
accurate representation of patterns of ASM across the
genome. MS-SNuPE analyses on bisulﬁte-treated DNA
from the same individuals also uncovered patterns of
DNA methylation consistent with ASM. Six loci were
selected for replication analysis in DNA obtained from
30 CEPH family trios. In each case, we were able to verify
the patterns of ASM observed in our initial set of samples.
The large number of samples in this replication stage, in
conjunction with the availability of parental genotypen Journal of Human Genetics 86, 196–212, February 12, 2010 199
Table 1. SNPs Showing Strong Evidence for an Association with
ASM as Demonstrated by an Average Change in RAS >0.30
Following MSRE Digestion
SNP ID
Average
RAS Change Location
Nearest
Gene
SNP_A-1844633
(rs7010076)
0.43 8q22.3 TM7SF4
SNP_A-1795087
(rs8179387)
0.39 1p36.12 CELA3B
SNP_A-4240542
(rs2731826)
0.38 5q15 TTC37
SNP_A-8327043
(rs17224644)
0.38 20p12.3 FERMT1
SNP_A-8694024
(rs10518694)
0.37 15q21.2 ONECUT1
SNP_A-1921713
(rs6760544)
0.36 2q21.1 RAB6C
SNP_A-8528087
(rs4796537)
0.35 17p13.2 MED31
SNP_A-8590194
(rs12084204)
0.35 1p36.13 CAPZB
SNP_A-1841543
(rs10234308)
0.34 7p15.3 MGC87042
SNP_A-1932077
(rs220030)
0.34 15q11.2 SNRPN
SNP_A-4258853
(rs4758622)
0.34 11p15.4 NAP1L4
SNP_A-8638885
(rs10148112)
0.33 14q32.2 CYP46A1
SNP_A-1898177
(rs8042219)
0.32 15q15.1 PLA2G4D
SNP_A-1899896
(rs4620270)
0.32 8q24.13 TRMT12
SNP_A-1784536
(rs3821023)
0.31 2p22.1 GALM
SNP_A-1859378
(rs6494120)
0.31 15q22.2 GCNT3
SNP_A-1871081
(rs629018)
0.31 19q13.11 LSM14A
SNP_A-4235888
(rs4573528)
0.31 1q41 HHLPI2
SNP_A-8444607
(rs2233287)
0.31 5q33.1 TNIP1
SNP_A-8444965
(rs4545169)
0.31 9q34.3 FCN2
SNP_A-8628263
(rs809722)
0.31 14q22.1 PTGDRinformation, allowed us to determine whether ASM was
associated with genomic sequence in cis or was inﬂuenced
by parental origin. Finally, we performed in-depth clonal
bisulﬁte sequencing, considered the ‘‘gold-standard’’
method for assessing allelic patterns of DNA methylation,
across four regions. Again these analyses conﬁrmed the
patterns of ASM predicted from our microarray screen
and subsequent veriﬁcation experiments.200 The American Journal of Human Genetics 86, 196–212, FebruaryTesting the Validity of Our Approach: Conﬁrming
ASM at Known Imprinted Regions
Figure 2 highlights the validity and power of our method
for mapping functional DMRs. We observe a large shift in
RAS for SNP_A-1932077 (rs220030) located within a
known ICE spanning the promoter and ﬁrst exon of
SNRPN (Figures 2A and 2B), known to control monoallelic
expression from the paternal allele of a cluster of imprinted
genes on 15q11.2.27 Across informative individuals, the
average RAS change for this SNP was 0.34, with array
results subsequently veriﬁed by single-nucleotide primer
extension assays (Figure 2C). Sodium bisulﬁte analysis of
CpG sites within MSRE cut-sites present in the amplicon
interrogated by the genotyping microarray conﬁrmed a
biphasic DNA methylation proﬁle across all samples
(Figure 2D), a pattern also observed in buccal cell DNA
from the same individuals. Neither DNA methylation at
this locus nor expression of SNRPN is associated in cis
with genotype, as expected for an imprinted region (Fig-
ure S3). Finally, we replicated the pattern of genotype-
independent ASM at this region in samples obtained
from 30 CEPH family trios, conﬁrming that DNA methyla-
tion occurs speciﬁcally on the maternally inherited allele
(see Figure 2E).
Our approach detected clear examples of ASM in the
vicinity of other known imprinted loci (Table 2). These
include large RAS changes for SNPs located near H19,
including several in the vicinity of the H19-DMR located
~2 kb upstream of the transcriptional start site. This region
is known to act as a boundary element, instigating mono-
allelic expression across a cluster of genes on 11p15 via
interactions with the vertebrate insulator protein,
CCCTC-binding factor.27 Several other large RAS changes
were identiﬁed in the 11p15 region, including at SNP_A-
4258853 (rs4758622), which provides evidence for strong
allelic skewing of DNA methylation in the ﬁrst intron of
NAP1L4. Contradictory evidence exists about whether
the mouse ortholog of this gene (Nap1l4) is imprinted,28
and its status in humans is unknown. Intriguingly, our
data suggest that the ASM at this region is not due to
imprinting but appears to be caused by cis-acting genetic
effects (Figure S4).
The utility of our approach for identifying the location of
DMRs associated with known imprinted genes is exempli-
ﬁed by evidence for an average RAS change of 0.24 at
SNP_A-8486811 (rs11883960). This SNP is located down-
stream of LLRTM1 on chromosome 2p12, within an intron
of CTNNA2 (Figure S5A). Genetic polymorphisms in
LLRTM1 have been associated with schizophrenia (MIM
181500) in a parental-origin-speciﬁc manner, and the
genewaspreviously shown tobemonoallelically expressed,
presumably because of imprinting.29 Previous analyses of
three CpG islands immediately upstream of the gene failed
to detect any ASM, and the location of the DMR associated
with monoallelic expression is unknown.29 Although we
are unable to conclusively determine that this region is
inﬂuenced by genomic imprinting, our data provide12, 2010
evidence for a DMR located ~250 kb downstream of the
transcription start site in a region not classically deﬁned as
a CpG island. Microarray data suggest that rather than
being characterized by totalmonoallelic DNAmethylation,
this region showsmore subtle allelic skewing of DNAmeth-
ylation (Figure S5B), a conclusion conﬁrmed by our SNuPE
veriﬁcation experiments with the average G/A allelic ratio
switching from 1.9 in heterozygous genomic DNA samples
to 2.5 in MSRE-digested heterozygous samples.
One of the loci selected for further investigation demon-
strates evidence for parental-origin-mediated ASM in a
genomic region not previously known to be imprinted.
SNP_A-1782879 (rs17427250), located at 5q34 upstream
of ATP10B and downstream of GABRB2, was found to
have an average RAS change of 0.30 in heterozygous indi-
viduals (Figures 3A and 3B), an observation conﬁrmed by
SNuPE analysis (Figure 3C). Interestingly, this ASM appears
to be tissue speciﬁc; our original analyses on blood DNA
highlight almost complete loss of one allele following
MSRE digestion in heterozygotes; this is not the case in
buccal cell DNA from the same individuals (Figure 3C).
Clonal bisulﬁte sequencing across this region in blood
conﬁrms a pattern of biphasic DNA methylation at an
AciI cut-site (Figure 3D). Direct bisulﬁte sequencing found
this site to be consistently hemimethylated in blood DNA
but fully methylated in buccal DNA obtained from the
same individuals (Figure 3E). Loss of heterozygosity
following MSRE digestion was conﬁrmed in the 30 CEPH
trios, with different alleles being cleaved in different indi-
viduals (Figure 3F). Such a pattern of allelic ﬂipping is
consistent with genomic imprinting, and we conﬁrmed
using parental genotypes that it is the paternally inherited
allele that is always cleaved (unmethylated). It has been
previously shown that many imprinted regions show
marked changes in DNAmethylation during development
and can acquire tissue-speciﬁc ASM.30
cis-Regulated ASM Effects
Several examples of ASM at nonimprinted loci, presumably
occurring because of cis-acting genotypic effects on DNA
methylation, have been previously reported.8,9 We
conﬁrmed many of these previously identiﬁed examples
using our approach, again highlighting the validity of
our screening methods (Table 3 and Figure 4). In many
instances, the high density of informative SNPs in our
study, afforded by the use of multiple MSREs and a high-
resolution microarray platform, allowed more speciﬁc
localization of these previously identiﬁed ASM effects.
For example, a region located in intron 13 of the LTF
gene on chromosome 3p21.31 and within 1 kb of another
SNP (rs1042073) reported by Kerkel and colleagues to be
associated with strong cis-acting ASM8 was found to
contain three additional SNPs with signiﬁcant average
RAS changes in heterozygous individuals following MSRE
digestion: SNP_A-1972595 (rs6441990), SNP_A-2149420
(rs6441991), and SNP_A-1876897 (rs6441992) (see Figures
5A and 5B). Genotype-associated ASM at LTF SNPs wasThe Americaconﬁrmed using SNuPE analyses (Figures 5C and 5D) and
replicated in the CEPH family DNA from 30 trios (Figures
5E and 5F). At both SNP_A-1972595 (rs6441990) and
SNP_A-2149420 (rs6441991) we observe a highly signiﬁ-
cant change in allele ratio after MSRE digestion in hetero-
zygous individuals, conﬁrming a cis effect on ASM. For
SNP_A-1972595, there is a highly signiﬁcant loss in allele
G signal following MSRE digestion: as a proportion of the
total genotyping signal, the average level of allele G falls
from 0.78 (50.00) to 0.04 (50.10) after cleavage (p ¼
2.7E-29). For SNP_A-2149420 there is complete loss in
allele A signal following MSRE digestion: as a proportion
of the total genotyping signal, the average level of allele
A falls from 0.47 (50.08) to 0.00 (50.00) after cleavage
(p ¼ 0). Clonal bisulﬁte sequencing analysis of an ampli-
con spanning ten CpG sites revealed a clear pattern of
ASM associated with the three SNPs. G-A-A haplotypes
are associated with lower CpG methylation compared to
C-T-T haplotypes (10% versus 72%) across sites 1–4 span-
ning the three SNPs, including at an informative HpaII
site within the Affymetrix genotyping amplicon
(Figure 5G). Interestingly, this pattern of ASM only
extended to CpG sites in the immediate vicinity of the
three SNPs, indicating that cis effects on epigenotype can
be very local with discrete boundaries, an observation
also reported in other studies of ASM.9
From the genome-wide data generated, we selected
several previously unreported regions of cis-associated
ASM for additional analyses. One of the strongest average
RAS changes (0.36) was at SNP_A-1921713 (rs6760544),
located ~43 kb upstream of RAB6C (also known as
WTH3) on chromosome 2q21.1 (Figure 6A). After MSRE
digestion, individuals heterozygous for this SNP entirely
lose the signal from the T allele (Figure 6B). Individuals
with a homozygous TT genotype show a loss of all signal
following digestion, similar to the artiﬁcially unmethy-
lated samples we ran as assay controls. GG homozygotes
show no change in their signal intensity, showing that
they are fully methylated. These ﬁndings were veriﬁed
using independent SNuPE analyses and replicated in the
CEPH family trios (Figure 6C). Across CEPH samples
heterozygous for SNP_A-1921713 (rs6760544), there is
a highly signiﬁcant loss in allele T signal following MSRE
digestion: as a proportion of the total genotyping signal,
the level of allele T falls from 0.31 (50.05) to 0.07
(50.09) after cleavage (p¼ 5.6E-14). Sodium bisulﬁte anal-
yses of the two MSRE cut-sites in the amplicon containing
SNP_A-1921713 conﬁrmed that allele T is associated with
unmethylated DNA alleles and allele G with methylated
DNA alleles in both blood and buccal cell DNA
(Figure 6D). A pattern of near-complete cis-acting ASM
across multiple CpG sites in this region was conﬁrmed by
clonal bisulﬁte sequencing (Figure 6E). Strikingly, no
CpG sites in phase with allele T are methylated, but 83%
of those in phase with allele G are methylated.
We veriﬁed RAS changes following MSRE digestion for
several other SNPs where ASM appears to be associatedn Journal of Human Genetics 86, 196–212, February 12, 2010 201
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Figure 2. Strong ASM in the SNRPN Promoter Overlaps with a Region Previously Identified as a DMR Regulating Monoallelic Expres-
sion across the 15q11.2 Imprinted Gene Cluster
(A) The location of potentially informative fragments are shown in black, with the average RAS change in each of the ﬁve MZ twin pairs
for individual SNPs within each fragment shown as blue bars. This ﬁgure was adapted from an annotated UCSC Genome Browser track
containing all our microarray data, available for download from our laboratory website. Large RAS changes are seen in both twin pairs
heterozygous for SNP_A-1932077 (rs220030), located immediately upstream of the SNRPN transcription start site.
(B) Heat map of normalized array signal data for the three probes representing SNP_A-1932077 (rs220030). The genotype (G) demon-
strates a clear switch to monoallelic signal in the digested samples (D) for both members of twin pairs 2411 and 1990, who are hetero-
zygous for this polymorphism. A different allele is methylated in each pair, as might be expected in an imprinted locus. The remaining
three pairs are homozygous for SNP_A-1932077 (rs220030) and do not change in genotype call with digested DNA (columnD), but show
reduced signal intensity consistent with the loss of one parental allele. The unmethylated and digested samples (U) show a total loss of
signal across all samples assessed, so this pattern is not due to polymorphic MSRE cut-sites.
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Table 2. Examples of Informative ASM-Associated SNPs Located Near Known Imprinted Loci
Location SNP ID Average RAS Change Nearest Gene(s) Known Imprinted Genes in Region
2p12 SNP_A-8486811 (rs11883960) 0.24 CTNNA2a- LRRTM1 LRRTM1
6q25.3 SNP_A-2187171 (rs539958) 0.11 SLC22A3b IGF2R, SLC22A2, SLC22A3
7p12.2 SNP_A-8615031 (rs12719019) 0.14 IKZF1a DDC, GRB10
7q21.3 SNP_A-2262372 (rs1029391) 0.17 SLC25A13a PPP1R9A
11p15.4 SNP_A-4258853 (rs4758622) 0.34 NAP1L4c H19, IGF2, IGF2AS, INS, KCNQ1, KCNQ10T1, KCNQ1DN,
CDKN1C, SLC22A18, PHLDA2, OSBPL5
11p15.5 SNP_A-4301486 (rs2107425) 0.17 H19 H19, IGF2, IGF2AS, INS, KCNQ1, KCNQ10T1,
KCNQ1DN, CDKN1C, SLC22A18, PHLDA2, OSBPL5
SNP_A-8447191 (rs2735971) 0.10
SNP_A-8613640 (rs4930101) 0.21
SNP_A-8608669 (rs12417375) 0.19
SNP_A-8654762 (rs2735469) 0.18
11p15.5 SNP_A-8632218 (rs10840442) 0.11 INS-IGF2 H19, IGF2, IGF2AS, INS, KCNQ1, KCNQ10T1,
KCNQ1DN, CDKN1C, SLC22A18, PHLDA2, OSBPL5
14q32.2 SNP_A-8638885 (rs10148112) 0.33 EML1a DLK1, GTL2, RTL1
14q32.31 SNP_A-8303781 (rs1889364) 0.15 DIO3c DLK1, GTL2, RTL1
14q32.31 SNP_A-8417055 (rs10431745) 0.18 PPP2R5Ca DLK1, GTL2, RTL1
15q11.2 SNP_A-1932077 (rs220030) 0.34 SNURF-SNRPN MKRN3, MAGEL2, NDN, PWRN1, C15ORF2,
SNURF-SNRPN, UBE3A, ATP10A
19q13.41 SNP_A-8392857 (rs8105870) 0.22 ZNF331 ZNF331
SNP_A-8655708 (rs7248353) 0.20
19q13.43 SNP_A-8306238 (rs10412302) 0.15 MIMT1, ZIM2-PEG3 MIMT1, ZIM2, PEG3
20q13.32 SNP_A-8660497 (rs3761263) 0.17 GNAS GNAS
a Imprinting status unknown.
b Previously shown to exhibit only temporary imprinting, with monoallelic expression limited to the first-trimester placenta.
c Known to be imprinted in mouse, but status in humans is unknown.with genotype in cis, including at SNP_A-8638885
(rs10148112), located between CYP46A1 and EML1 on
chromosome 14q32.2 (Figure S6), and SNP_A-1795087
(rs8179387), located between HSPG2 and CELA3B on
chromosome 1p36.12 (Figure S7). Another locus, SNP_A-
2002432 (rs4936180), located at 11q25 within the OPCML
gene (Figure 7A), exempliﬁes how cis-associated ASM can
be heterogeneous between individuals and across tissues.
At this SNP, we observe a consistent reduction in allele C
signal across all heterozygote (C/T) samples (average RAS
change ¼ 0.19) (Figure 7B). The loss of allele C is not abso-
lute in all samples; C/C homozygotes show some residual
microarray signal, and loss of heterozygosity is not total
in all heterozygotes, an observation conﬁrmed in both
our SNuPE veriﬁcation assays and replication analysis on
the 30 CEPH family trios (Figure 7C). Although there is a
highly signiﬁcant loss in allele G signal following MSRE(C) Veriﬁcation of the microarray data using SNuPE conﬁrms a sw
Shown are data from one member of each twin pair, conﬁrming the
(D) MS-SNuPE analysis of a HhaI MSRE cut-site in the SNP_A-19320
(E) Data from 90 familial CEPH samples showing complete loss of het
across individuals.
The Americadigestion (as a proportion of the total genotyping signal,
the level of allele G falls from 0.34 [50.06] to 0.03
[50.09] after cleavage in C/T heterozygotes [p ¼
3.9E-20]), the CEPH data conﬁrm the incomplete nature
of ASM at this locus. C/C homozygotes demonstrate
a highly signiﬁcant (p ¼ 9.6E-09) loss of total SNuPE signal
intensity following MSRE digestion, but there is consider-
able variability, with some individuals showing total abla-
tion of signal and other individuals much more modest
changes. Sodium bisulﬁte analysis, via both MS-SNuPE
and clonal bisulﬁte sequencing, demonstrates that there
is some residual DNA methylation at an informative AciI
cut-site in the SNP_A-2002432 amplicon present on
many C alleles (Figure 7D). CC homozygous individuals
that don’t show a total ablation of signal have an average
DNA methylation level of 8% at this MSRE cut-site. We
also tested ASM for this SNP in buccal cell DNA, ﬁndingitch to monoallelic genotype in digested heterozygous samples.
loss of alternative alleles in each family.
77 amplicon conﬁrms this region is hemimethylated.
erozygosity after MSRE digestion, with a variable direction of ASM
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Figure 3. Evidence for Tissue-Specific ASM Associated with Parental Origin at SNP_A-1782879 (rs17427250), Located at 5q34
Upstream of ATP10B
(A and B) Location of the SNP showing an average RAS change of 0.30 in heterozygous individuals corresponding to almost complete loss
of signal from one allele following MSRE digestion (B).
(C) These ﬁndings were veriﬁed using SNuPE in the original blood DNA, but there is no evidence of ASM in buccal cell DNA from the
same individuals.
(D) Clonal bisulﬁte sequencing conﬁrmed this is a DMR, with a biphasic DNAmethylation pattern at an informative AciI MSRE cut-site
in the Affymetrix SNP amplicon.
(E) Bisulﬁte sequencing in samples from family 1990 conﬁrms tissue-speciﬁc differences in ASM, with blood samples showing a mixture
of methylated and unmethylated alleles but buccal samples being fully methylated, including at an informative AciI site in the Affyme-
trix SNP amplicon.
(F) Analysis of ASM at this SNP in 30 CEPH family trios (n ¼ 90 individuals) demonstrated consistent loss of heterozygosity following
MSRE digestion, although the effect was not in cis with genotype and likely due to genomic imprinting.
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Table 3. Examples of Informative ASM-Associated SNPs in Regions with Known Parental-Origin-Independent ASM
Location SNP ID Average RAS Change Nearest Gene(s) Previous Evidence for Genotype-Associated ASM
3p21.31 SNP_A-1972595 (rs6441990) 0.24 LTF Another SNP located in exon 13 of this gene was
found to show ASM by Kerkel et al.8
3p21.31 SNP_A-2149420 (rs6441991) 0.14 LTF See above.
3p21.31 SNP_A-1876897 (rs6441992) 0.16 LTF See above.
6p21.2 SNP_A-4250374 (rs9366927) 0.19 FGD2-PIM1 The same SNP was identiﬁed as showing ASM
in Kerkel et al.8
13q12.12 SNP_A-2065646 (rs943049) 0.23 LOC374491
(between PARP4 and ATP12A)
The same SNP was identiﬁed as showing ASM
in Kerkel et al.8
15q22.2 SNP_A-1859378 (rs6494120) 0.31 GCNT3 The same SNP was identiﬁed as showing ASM
in Kerkel et al.8
19q13.2 SNP_A-8631787 (rs13382161) 0.18 CYP2F1 Two SNPs in the CYP2 cluster shown to demonstrate
ASM in a subsection of samples by Kerkel et al.8
21q22.3 SNP_A-2020619 (rs2236472) 0.27 COL18A1 Allele-speciﬁc, parental-origin-independent
methylation detected upstream of SLC19A1,
immediately adjacent to COL18A1.17
Examples of informative ASM-associated SNPs located near regions previously shown to demonstrate parental-origin-independent ASM.evidence for tissue heterogeneity in ASM within individ-
uals; in contrast to blood, no heterozygous buccal samples
show a complete loss of the C allele following MSRE diges-
tion, but there is still strong allelic skewing, and some indi-
viduals demonstrate stronger skewing in buccal DNA than
blood DNA (Figure 7E). Furthermore, C/C homozygote
buccal samples do not show the near total loss of signal
seen in blood samples following MSRE digestion and are
characterized by DNA methylation patterns similar to
those seen in heterozygotes. It has been recently demon-
strated that tissue-speciﬁc cis effects on gene expression
are relatively common,13,31 and our data suggest that
such heterogeneity could be mediated by epigenetic differ-
ences. Evidence to support the notion that the expression
of OPCML is regulated by genotype-associated ASM comes
from our transcriptomic data on the same set of blood
samples; C/C homozygotes show signiﬁcantly higher
expression than C/T heterozygotes (Figure 7F). Interest-
ingly, loss of OPCML expression in ovarian cancer (MIM
167000) has been previously associated with increased
CpG methylation in the gene.32
ASM-Associated SNPs and Gene Expression
Given that DNA methylation is linked to the regulation of
gene expression,1 we postulated that any cis-acting ASM-
associated SNPs might be linearly associated with the
expression of nearby genes. Reliable estimates of gene
expression were obtained from the same samples by
proﬁling whole-blood mRNA from each individual four
times over a 10 month period (see Material and Methods).
Of the 2704 informative SNPs with a RAS change R0.10,
651 map to within 5 kb of a gene expressed at detectable
levels in blood. Samples were grouped by genotype for
each SNP, and transcript levels across genotype groups
were assessed using a linear effects model for each probe
set. Because some SNPs are located within 5 kb of moreThe Americathan one gene and each gene can be represented by more
than one expression probe set, 1316 such SNP-expression
associations were tested. Strikingly, 214 (16.3%) provided
evidence for a signiﬁcant (p < 0.05) linear association
between genotype and transcript abundance, conﬁrming
the notion thatmany of the ASM effects we detect correlate
with allelic expression differences that are likely to be cis in
nature (Table S3). As examples, Figure 8 and Table S4 high-
light the ﬁve most signiﬁcant such associations, for SNPs
located near CD180, PRUNE2, CHST13, HPCAL1, and
C12orf47. Out of the ASM regions detected in our study
for which there was previous evidence of ASM (see Table
3 and Figure 4), reliable levels of expression in blood were
obtained only for COL18A in which SNP_A-2020619
(rs2236472) has an average RAS change of 0.27 across
heterozygous individuals. Interestingly, genotype is signif-
icantly associated with transcript abundance (Figure 9),
suggesting a cis-acting effect on gene expression that is
mediated by ASM. As expected, no consistent relationship
between genotype and transcript abundance was observed
for ASM-associated SNPs located near known imprinted
loci; ASE of imprinted genes is controlled by the parental
origin of alleles and not by genotype. The full expression
data set for ASM-associated SNPs can be seen online at
our group website.
In addition to testing whether patterns of allelic DNA
methylation are associated with steady-state mRNA levels
from the same tissue, we incorporated data from a recent
genome-wide survey of ASE by Ge and colleagues33 into
our analysis of ASM. A UCSC track showing ASE data from
this study is downloadable from our website. As an
example, COL18A (see discussion above) contains a SNP
demonstrating highly skewed allelic expression, further
supporting the notion that the ASM detected at SNP_A-
2020619 (rs2236472) directly mediates ASE. Overall, our
2704 SNPs with a RAS change R0.10 correspond to 1565n Journal of Human Genetics 86, 196–212, February 12, 2010 205
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Figure 4. Confirmation of Previously Identified cis-Acting ASM
(A–D)We conﬁrmed several previously identiﬁed examples of ASMwith large RAS changes followingMSRE digestion identiﬁed for SNPs
near LOC374491 (A), CYP2F1 (B), GCNT3 (C), FGD2-PIM1 (D), and LTF (see Figure 5). See also Table 3.
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Figure 5. Intron 13 of the LTF Gene Contains Three SNPs Associated with ASM in cis
(A) Location of SNP_A-1972595 (rs6441990), SNP_A-2149420 (rs6441991), and SNP_A-1876897 (rs6441992) with the average RAS
change across heterozygous individuals shown as blue bars.
(B) Heat map of normalized array signal data for the three probes representing SNP_A-1972595 (rs6441990), demonstrating a consistent
loss of heterozygosity following MSRE digestion.
(C and D) Microarray data were veriﬁed using SNuPE analyses. Shown are examples for (C) (SNP_A-1972595 [rs6441990]) and (D)
(SNP_A-2149420 [rs6441991]).
(E and F) cis-acting ASM was conﬁrmed in the 30 CEPH family trios. Shown are data for (E) (SNP_A-1972595 [rs6441990]) and (F)
(SNP_A-2149420 [rs6441991]).
(G) Clonal bisulﬁte sequencing conﬁrmed that G-A-A haplotypes are associated with lower DNA methylation (10%) compared to C-T-T
haplotypes for four CpG sites spanning the three SNPs, including an informative HpaII site.well-annotated loci34 (see Web Resources), of which 451
(28.8%) contain a SNP with an ASE score >0.10 in the
data obtained from Ge and colleagues.33 These genes are
available to download from our laboratory website. Permu-
tation analysis randomly sampling SNPs from the ASE data
indicated this represents a signiﬁcant enrichment, suggest-
ing that many of the genes located in the vicinity ofThe AmericaASM-associated SNPs demonstrate allelically skewed
expression (p < 0.05, 5000 permutations).
Discussion
Using a comprehensive enrichment strategy, high-resolu-
tion microarrays, and a novel analytical approach, wen Journal of Human Genetics 86, 196–212, February 12, 2010 207
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Figure 6. Analysis of SNP_A-1921713 (rs6760544) LocatedUpstreamof RAB6C, which Shows Strong Evidence for a cis-Regulated ASM
(A) Location of the SNP ~43 kb upstream of RAB6C showing an average RAS change of 0.36.
(B) Heat map of normalized microarray signal data for the three probes representing this SNP. Signals for the G allele do not differ
between columns G and D, but the T allele signals are reduced to nearly the levels of the U (unmethylated) column. This complete
MSRE digestion shows that the T allele carrying haplotype is unmethylated.
(C) A pattern of cis-acting ASM associated with SNP_A-1921713 (rs6760544) was conﬁrmed in the 30 CEPH family trios.
(D) Bisulﬁte analysis at the HhaI and AciI MSRE cut-sites in the fragment incorporating rs6760544 conﬁrms that DNA molecules con-
taining allele T are unmethylated and DNA molecules containing allele G are methylated. This pattern is consistent across blood and
buccal cell DNA and observed in all samples tested.
(E) Clonal bisulﬁte sequencing conﬁrmed a clear allelic association with DNAmethylation across six CpG sites, including two located in
informative MSRE cut-sites contained within the Affymetrix genotyping amplicon.have, to our knowledge, performed the ﬁrst large-scale
quantitative survey of ASM across the genome. Our data
show that ASM is widespread and mediated by both
parental-origin (imprinting) and cis effects. Furthermore,208 The American Journal of Human Genetics 86, 196–212, Februarywe show that ASM is often associated with changes in tran-
script abundance and that there is considerable heteroge-
neity between individuals and across tissues. Our ASM
data are freely available via fully annotated UCSC Genome12, 2010
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Figure 7. Analysis of SNP_A-2002432 (rs4936180) LocatedwithinOPCML, which Shows Evidence of Tissue-Specific cis-Mediated ASM
(A–C) Location of the SNP, which shows an average RAS change of 0.19 across heterozygous individuals and is characterized by reduction
of the C allele signal following MSRE digestion in blood DNA (B). The loss of allele C is not always complete; C/C homozygotes show
some residual microarray signal, and loss of heterozygosity is not total in all heterozygotes, an observation conﬁrmed in both our SNuPE
veriﬁcation assays and replication analysis (C) on the 30 CEPH family trios.
(D) Bisulﬁte analysis of an AciI MSRE site support these data and highlight heterogeneity between samples, with some residual DNA
methylation present on some C alleles; a biphasic, although not complete, pattern of DNA methylation at this MSRE site is conﬁrmed
by clonal bisulﬁte sequencing.
(E) ASM at this locus is characterized by considerable tissue heterogeneity.
(F) OPCML expression in blood is signiﬁcantly associated with genotype at both SNP_A-2002432 (p < 0.02) and another nearby
ASM-associated locus, SNP_A-2121632 (rs10791256) (p < 0.04), which shows an average RAS change of 0.12 across heterozygous
individuals.
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Figure 8. Examples of Association between Genotype at ASM-Associated SNPs and Gene Expression
Genotype was compared with gene expression at nearby (<5 kb) genes using a linear model. An unadjusted p < 0.0001 cutoff was
applied. Of the 5 genes presented, 2 are represented by more than one microarray probe set; shown are the most signiﬁcant probe
sets, but in each case the other probes in the same transcript show signiﬁcant (p < 0.005) expression changes in the same direction
(205462_at in HPCAL1 and 64432_at and 1553987_at in C12orf47). In total, >16% of loci demonstrating a change in RAS >0.10
following MSRE digestion, for which reliable expression data are available, show a signiﬁcant linear association between genotype
and transcript abundance.Browser tracks that provide a valuable resource for the
(epi)genetics research community.
Five lines of evidence conﬁrm that our microarray-based
screen of allelic changes following MSRE digestion is
tagging real allelic differences in DNA methylation. First,
as described under Material and Methods, we have taken
an extremely stringent approach to data analysis in order
to avoid false-positive observations. In addition, we
included parallel analyses of fully unmethylated DNA
samples from the same individuals to overcome the con-
founding effect of polymorphic SNPs in MSRE cut-sites.
Second, many of the regions identiﬁed as showing large
changes in RAS followingMSREdigestion in ourmicroarray
screen are located either in the vicinity of DMRs associated
with known imprinted loci or near regions previously
nominated as containing cis-acting variants associated
with ASM (see Tables 2 and 3). Third, we have succeeded
in verifying each of ten selected ASM-associated SNPs using
a second quantitative genotyping method on the same
samples. Fourth, we replicated these ﬁndings in an inde-
pendent set of 30 CEPH family trios (90 individuals); the
relatively large number of replication samples and their
familial nature meant we could deduce whether ASM
patterns at each locus were due to cis effects of genotype
or parental-origin inﬂuences (i.e., genomic imprinting).
Finally, we directly assessed DNA methylation across
relevant MSRE cut-sites contained in the Affymetrix
amplicons for each SNP using two sensitive methods of
quantitative DNA methylation proﬁling: (1) MS-SNuPE
and (2) the clonal sequencing of bisulﬁte PCR amplicons.
The latter uncovered clear biphasic patterns of DNA meth-
ylation, linked to genotype, across each of the amplicons
tested.
Our ﬁndings have profound implications for genetic
studies of complex disease. The most common category of
ASM, what we call cis effects, must be due to local sequence
features. This provides one mechanism by which noncod-210 The American Journal of Human Genetics 86, 196–212, Februarying sequence features can have phenotypic effects. For
example, DNA methylation displaces the binding of tran-
scription factors and attracts methyl-binding proteins that
instigate chromatin compaction and gene silencing. There
is a clear quantitative distribution of RAS changes in our
data set, and bisulﬁte sequencing conﬁrms incomplete
ASM in many instances. ASM is also heterogeneous
between individuals and across tissues. Such heterogeneity
in cis effects could be one cause for the small effect sizes and
lack of replication often observed in genetic association
studies. Additionally, in a substantial number of loci
(~10%), we ﬁnd evidence that the direction of ASM varies
between individuals. This observation suggests that
non-cis effects such as genomic imprinting, complex
trans-acting factors, or stochasticity are important in deter-
mining some instances of ASM. Such non-cis ASM poses a
problem for genome-wide association studies (GWAS) and
could explain the ‘‘missing heritability’’ associated with
most common human diseases;35 it can render loci effec-
tively hemizygous and dilutes or breaks allelic association.
The current number of known imprinted human genes
(i.e., between 40 and 50) is too low to account for the
number of non-cis effects we see. Our data support the
notion that parental-origin effects on gene function might
be more widespread than traditionally believed,4 exempli-
ﬁed by the pattern of ASM we uncovered at SNP_A-
1782879 (rs17427250), which is indicative of genomic
imprinting. Finally, risk for complex disease is now recog-
nized as resulting from interactions between both the
genome and the environment,36 but the mechanism
behind such gene by environment interplay is unknown.
Increasing evidence suggests that epigenetic processes
such as DNA methylation can be inﬂuenced by a range of
external environmental factors, including diet, toxins,
drugs, and stress.37 Our data, demonstrating that polymor-
phisms can exert an effect on gene function via epigenetic
processes such as ASM occurring in cis, suggest a common12, 2010
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Figure 9. cis-Acting ASMNear COL18A1 Is Associated with Gene
Expression
The abundance of COL18A1 transcripts, as measured by two Affy-
metrix gene expression microarray probe sets, is associated with
genotype at SNP_A-2020619 (rs2236472), suggesting that ASM at
this locus has a direct effect on transcription.pathway behind both genetic and environmental effects
and a potential mechanism for gene by environment inter-
action. Our ﬁndings indicate that a comprehensive epige-
netic analysis of candidate SNPs and haplotypes is war-
ranted and that integrating genome-wide ASM screens
into current GWA strategies will be a useful approach.
The ASM data set produced in this study represents an
essential ﬁrst step toward this approach, and the web
resource we have developed can be used by the GWA
research community to aid in the interpretation of appar-
ently nonfunctional sequence changes that are associated
with disease.
To conclude, we performed a systematic screen of ASM
across the genome with the aim of identifying previously
unreported DMRs associated with either genomic im-
printing or DNA sequence variation. We employed high-
resolution microarrays and a novel analytical approach
to quantitatively assess changes in RAS at ~1 million
SNPs following digestion with MSREs. Taken together,
our data show that ASM is widespread (occurring at
>35,000 sites across the genome) and likely to be associ-
ated with both parental-origin and cis effects on gene
expression. Using RNA from the same blood samples, we
were able to linearly correlate ASM with gene expression,
and using a second source of DNA from each individual,
we were able to identify several examples of tissue-speciﬁc
ASM. Our data suggest that a spectrum of ASM is likely,
with heterogeneity between individuals and across tissues.
These ﬁndings impact our understanding about the
origin of individual phenotypic differences and haveThe Americaimplications for genetic studies of complex disease and
phenotypic variation.Supplemental Data
Supplemental Data include seven ﬁgures and four tables and can
be found with this article online at http://www.ajhg.org.Acknowledgments
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